By Cole Bunn, Research Analyst, LSN
Family offices are an investor class that has recently garnered a lot of attention from life science entrepreneurs. Their wide variety of motivations and transaction types and generally speaking, more flexible term sheets, make these investors a great partner for biotech companies undertaking the daunting task of commercializing therapeutic products.
At RESI San Francisco, the Biotech Family Office Panel will provide insights into each represented firm’s current interests and outlook on the biotech sector, how they source and evaluate deals and their position in the investment ecosystem.
Moderated by Lisa Rhoads, Managing Director, Easton Capital, this panel will feature:
- Jim Mellon, Chairman & Founder, Mann Bioinvest
- Rick Jones, Director, Broadview Ventures
- Jayson Rieger, SVP of Business Development, PBM Capital Group
- Christine de los Reyes, Vice President, Alopexx Enterprises
If you’re interested in listening to this panel live at RESI, you can register for RESI San Francisco now. RESI provides a great opportunity to expand your network in the life sciences and to get a better understanding of fundraising process, and January 12th will be our largest gathering yet.